Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Bayer Increases Roundup Lawsuit Settlement Reserves By $4.5 Billion July 30, 2021 Irvin Jackson Add Your Comments Days after the U.S. District Judge presiding over all federal Roundup lawsuits required that plaintiffs diagnosed with non-Hodgkins lymphoma participate in a new process to obtain a settlement offer to resolve their case, Bayer has announced it is setting aside an additional $4.5 billion in reserves to cover costs associated with the litigation. Bayer and its Monsanto unit have faced more than 120,000 non-Hodgkins lymphoma (NHL) cases brought by former users of the controversial glyphosate-based weed killer, each raising similar allegations that information has been withheld from consumers about the risks associated with glyphosate exposure from Roundup. Last year, Bayer announced a massive Roundup settlement, which would involve payments of more than $11.6 billion to resolve previously filed claims against Monsanto. However, in addition to settling cases already filed by former users diagnosed with non-Hodgkins lymphoma, the company proposed a class action settlement that set aside about $2 billion to resolve future claims that may arise over the next four years. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The proposed settlement of future cases faced sharp criticism at the time, as former users of Roundup who have not yet been diagnosed with cancer, would not have a fair opportunity to opt out of the program. Under terms of that previously proposed deal, those individuals would have lost important rights, including a requirement they wait four years to pursue any future lawsuits over the deadly cancer, and give up the ability to pursue punitive damages, which have resulted in a number of massive verdicts against Monsanto. U.S. District Judge Vince Chhabria, who is overseeing the federal litigation, rejected that settlement plan in May, saying it would allow Bayer to treat future claimants who have not yet developed non-Hodgkins lymphoma after glyphosate exposure unfairly. The court noted non-Hodgkins lymphoma has a latency period of 10 to 15 years, but the agreement only provided a four-year window to file. As new cases continue to be filed by individuals diagnosed with NHL, and thousands of lawsuits remain unsettled, Judge Chhabria issued an order last week requiring every current and future plaintiff with a case in the federal court system who has not already reached a settlement with Bayer to participate in a mediation program with Special Master Ken Feinberg, who has established a program that allows each plaintiff to obtain an offer to settle their Roundup NHL case. Plaintiffs are not required to accepted the settlement, and Judge Chhabria is pushing forward with plans to prepare several large waves of cases for trial while the mediation program moves forward. On Thursday, Bayer officials announced they are adding another $4.5 billion in reserves to cover the costs of the Roundup litigation and settlements that are continuing to be negotiated. The company also announced the same day that it plans to remove the active ingredient glyphosate from Roundup weed killers sold to U.S. residential customers by 2023. The products would still be sold under the Roundup label, but would use a different active ingredient, which has not been linked to a risk of non-Hodgkins lymphoma. However, glyphosate would still be used in products sold to agricultural businesses and farmers, and in product sold in other parts of the world, Bayer officials said. While the move may eventually limit the filing of new non-Hodgkins lymphoma lawsuits against Bayer and it’s Monsanto subsidiary for failing to warn about the risks associated with glyphosate, the companies will still face years of future litigation and thousands of additional lawsuits brought as long-time users continue to develop non-Hodgkins lymphoma after exposure to the product during the decades it has been on the market without any cancer warnings. Bayer has noted the vast majority of Roundup cancer claims have come from U.S. residential users, and the additional set aside will raise the total cost of the litigation to more than $16 billion. Tags: Bayer, Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Georgia Lawmakers Agree To Shield Bayer From Roundup Cancer Lawsuits May 15, 2025 Roundup Exposure May Increase Infertility, Endometriosis Risks: Study May 1, 2025 Bayer Appeals Roundup Lawsuits to U.S. Supreme Court Again April 7, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: today) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: yesterday) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025) Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (Posted: 2 days ago) Hair relaxer lawsuit plaintiffs and defendants have selected 32 claims to be prepared for early test trials, focusing on ovarian, uterine and endometrial cancer injuries. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: today) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: yesterday) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (Posted: 2 days ago) Hair relaxer lawsuit plaintiffs and defendants have selected 32 claims to be prepared for early test trials, focusing on ovarian, uterine and endometrial cancer injuries. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)